Back to top
more

Quest Diagnostics (DGX)

(Delayed Data from NYSE)

$155.29 USD

155.29
1,094,683

+0.46 (0.30%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $155.34 +0.05 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (29 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Ecolab's New Pest Elimination Service to Ensure Food Safety

Ecolab's (ECL) introduces Rodent Ceiling Service, which can help reduce the risk to food safety and public health.

Here's Why You Should Add Surmodics to Your Portfolio Now

Investor confidence is high on Surmodics (SRDX), thanks to solid prospects.

Conformis Next-Generation Identity PS Knee System Gets FDA Nod

Conformis' (CFMS) latest iTotal Identity PS Knee System clears FDA hurdle, paving the way for providing better patient-specific pre-operative surgical plans.

Urmimala Biswas headshot

3 Best GARP Stocks to Beat Pandemic-Led Market Inefficiency

The unprecedented global health crisis is providing a psychological shock to the investment world.

NextGen Virtual Visits Supports Women Health During COVID-19

Capital Women's Care is set to expand NextGen's (NXGN) women's healthcare services during the coronavirus emergency.

Patterson Companies (PDCO) Q4 Earnings Top Estimates, Up Y/Y

Patterson Companies' (PDCO) fiscal fourth-quarter results reflect dismal performance by Dental and Animal Health segments.

Masimo (MASI) Boosts Product Portfolio with New Solution

Masimo (MASI) unveils Masimo Sleep to help consumers better understand their quality of sleep.

Amedisys Rides on Hospice Arm Expansion Amid Coronavirus Woes

Amedisys (AMED) benefits from the recent acquisitions of hospice care providers, Asana Hospice, RoseRock Healthcare and Compassionate Care Hospice.

Medtronic's Evolut TAVI Gets CE Mark for Low-Risk Patients

Medtronic's (MDT) Evolut system shows a lower rate of the composite of all-cause death or disabling stroke with TAVI at 30 days.

What's in Store for Patterson Companies' (PDCO) Q4 Earnings?

Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect solid performance at Dental segment.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, intense competition remains a woe.

Zimmer Biomet Adds New Features to mymobility with Apple Watch

Zimmer Biomet (ZBH) expands mymobility digital platform by leveraging Apple's ecosystem to enhance patients' post-operative care.

Allscripts' (MDRX) Veradigm Partners with PAN Foundation

This partnership between Allscripts (MDRX) and PAN Foundation is expected to boost patient outcomes.

Thermo Fisher Grows on Coronavirus Diagnostic Tests Amid Crisis

Thermo Fisher (TMO) is optimistic about ramped up production for its COVID-19 diagnostic test to meet growing global demand.

NuVasive Launches Reline 3D for Pediatric Patients Globally

Other than Reline 3D, NuVasive's (NUVA) Reline System portfolio has products like Reline Open, Reline MAS, Reline Trauma and Reline Small Stature.

Here's Why You Should Hold on to NuVasive (NUVA) Stock Now

Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently-launched products as well as solid international business.

Medtronic Partners Foxconn to Scale Up Ventilator Production

Medtronic (MDT) enters into a partnership with Foxconn with an aim of providing 10,000 PB560 ventilators in the United States over the next year amid the pandemic-led surge in demand for the same.

PerkinElmer's Tie-Up to Boost Health Outcomes in Africa

PerkinElmer's (PKI) partnership with ASH likely to boost newborn screening in underserved populations for better health outcomes in Africa.

Henry Schein Dental Software Arm May Rebound Despite Pandemic

Henry Schein (HSIC) also seems to be upbeat about its dental technology business, Henry Schein One.

Walgreens' Retail Pharmacy Grows Amid Coronavirus Crisis

Walgreens' (WBA) tie-ups with Alphabet's life sciences and healthcare segment, Verily on multiple projects related to chronic ailments buoy optimism.

DGX vs. AMED: Which Stock Is the Better Value Option?

DGX vs. AMED: Which Stock Is the Better Value Option?

Illumina Takes Over BlueBee, Fortifies NGS Data Processing

With this acquisition, the cloud capability of BlueBee's platform will help Illumina (ILMN) to lower the cost of storing, sharing and managing the company's huge volumes of genomic data.

Tandem Diabetes Gets Expanded Indication for Insulin Pump

Tandem Diabetes (TNDM) receives clearance for expanded indication for pediatric use of t:slim X2 insulin pump with Control-IQ, paving the way for simpler diabetes management in younger patient pool.

Accuray's New CyberKnife S7 System to Boost Patient Care

Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.

Myriad Genetics' Prolaris Receives Favorable Coverage Policies

Myriad Genetics (MYGN) paves the way for bringing more prostate cancer patients under the purview of Prolaris testing through their health plan.